Literature DB >> 8735093

Isolation of Ehrlichia canis from dogs following subcutaneous inoculation.

S D Gaunt1, R E Corstvet, C M Berry, B Brennan.   

Abstract

Subcutaneous inoculation of dogs with Ehrlichia canis was investigated as a more appropriate model of canine ehrlichiosis, which is naturally transmitted by arthropod vectors. A dose-dependent response occurred following subcutaneous inoculation of seven groups of dogs with log concentrations of E. canis-infected canine-origin cells. Ehrlichial infection in dogs was defined as concurrence of an increased titer of anti-E. canis immunoglobulin G (IgG) antibody in serum, a decreased platelet concentration, and isolation of E. canis by blood culture. In dogs administered the two lowest doses, no changes were detected. In seven of nine dogs administered three intermediate doses, the only change detected was a transient and mild increase in the anti-E. canis IgG antibody titer in serum. Only two of nine dogs inoculated with the intermediate doses developed an ehrlichial infection. Five of six dogs administered the two highest dose of E. canis developed an ehrlichial infection. These dogs had the highest IgG antibody titers in serum and the earliest isolation of E. canis from blood. In dogs that developed an ehrlichial infection, thrombocytopenia occurred by 28 days after inoculation, while increased IgG antibody titers in serum and blood cultures positive for E. canis occurred as early as 14 days postinoculation. Thrombocytopenia and seroconversion occurred later in the course of infection than previously reported for ehrlichial infections induced by intravenous inoculation. The route of administration and E. canis inoculum size can influence the course of ehrlichial infection and should be regarded as important variables in experimentally induced canine ehrlichiosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735093      PMCID: PMC229037          DOI: 10.1128/jcm.34.6.1429-1432.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Transmission of Ehrlichia canis to dogs by ticks (Rhipicephalus sanguineus).

Authors:  M G Groves; G L Dennis; H L Amyx; D L Huxsoll
Journal:  Am J Vet Res       Date:  1975-07       Impact factor: 1.156

2.  Investigation of renal protein loss in dogs with acute experimentally induced Ehrlichia canis infection.

Authors:  E C Codner; W R Maslin
Journal:  Am J Vet Res       Date:  1992-03       Impact factor: 1.156

3.  Acute canine ehrlichiosis: platelet survival and factor 3 assay.

Authors:  K R Pierce; G E Marrs; D Hightower
Journal:  Am J Vet Res       Date:  1977-11       Impact factor: 1.156

4.  Clinical and hematologic findings in canine ehrlichiosis.

Authors:  N F Kuehn; S D Gaunt
Journal:  J Am Vet Med Assoc       Date:  1985-02-15       Impact factor: 1.936

5.  Serum complement and blood platelet adhesiveness in acute canine ehrlichiosis.

Authors:  S L Lovering; K R Pierce; L G Adams
Journal:  Am J Vet Res       Date:  1980-08       Impact factor: 1.156

6.  Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment.

Authors:  Z Iqbal; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Comparison of PCR with other tests for early diagnosis of canine ehrlichiosis.

Authors:  Z Iqbal; W Chaichanasiriwithaya; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Kinetics of antibody response to Ehrlichia canis assayed by the indirect fluorescent antibody method.

Authors:  R M Weisiger; M Ristic; D L Huxsoll
Journal:  Am J Vet Res       Date:  1975-05       Impact factor: 1.156

9.  Acute experimental canine ehrlichiosis. I. Sequential reaction of the hemic and lymphoreticular systems.

Authors:  M J Reardon; K R Pierce
Journal:  Vet Pathol       Date:  1981-01       Impact factor: 2.221

10.  Tropical canine pancytopenia: Clinical, hematologic, and serologic response of dogs to Ehrlichia canis infection, tetracycline therapy, and challenge inoculation.

Authors:  W C Buhles; D L Huxsoll; M Ristic
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

  10 in total
  16 in total

1.  Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks.

Authors:  N Pusterla; C M Leutenegger; J S Chae; H Lutz; R B Kimsey; J S Dumler; J E Madigan
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Efficacy of a doxycycline treatment regimen initiated during three different phases of experimental ehrlichiosis.

Authors:  Jennifer C McClure; Michelle L Crothers; John J Schaefer; Patrick D Stanley; Glen R Needham; S A Ewing; Roger W Stich
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

3.  Immunodiagnosis of Ehrlichia canis infection with recombinant proteins.

Authors:  J W McBride; R E Corstvet; E B Breitschwerdt; D H Walker
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Kinetics of antibody response to Ehrlichia canis immunoreactive proteins.

Authors:  Jere W McBride; Richard E Corstvet; Steven D Gaunt; Charles Boudreaux; Thaya Guedry; David H Walker
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  A Tick Vector Transmission Model of Monocytotropic Ehrlichiosis.

Authors:  Tais Berelli Saito; David H Walker
Journal:  J Infect Dis       Date:  2015-03-03       Impact factor: 5.226

6.  Transstadial and intrastadial experimental transmission of Ehrlichia canis by male Rhipicephalus sanguineus.

Authors:  William G Bremer; John J Schaefer; Elizabeth R Wagner; S A Ewing; Yasuko Rikihisa; Glen R Needham; Sathaporn Jittapalapong; Debra L Moore; Roger W Stich
Journal:  Vet Parasitol       Date:  2005-07-15       Impact factor: 2.738

7.  Enzyme-linked immunosorbent assay with conserved immunoreactive glycoproteins gp36 and gp19 has enhanced sensitivity and provides species-specific immunodiagnosis of Ehrlichia canis infection.

Authors:  Ana Maria Cárdenas; C Kuyler Doyle; Xiaofeng Zhang; Kimberly Nethery; Richard E Corstvet; David H Walker; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2006-12-06

8.  Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Experimental infection and co-infection of dogs with Anaplasma platys and Ehrlichia canis: hematologic, serologic and molecular findings.

Authors:  Sd Gaunt; Mj Beall; Ba Stillman; L Lorentzen; Ppvp Diniz; R Chandrashekar; Eb Breitschwerdt
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

Review 10.  Host surveys, ixodid tick biology and transmission scenarios as related to the tick-borne pathogen, Ehrlichia canis.

Authors:  R W Stich; John J Schaefer; William G Bremer; Glen R Needham; Sathaporn Jittapalapong
Journal:  Vet Parasitol       Date:  2008-09-12       Impact factor: 2.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.